SCHEMBL28111660

SCHEMBL28111660

Nc1c[c]cc(C2CC2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292337 0.90 BACE1 (0.38)
SCHEMBL16950570 0.85 POLB (0.35)
SCHEMBL17133924 0.75 ESR2 (0.34)
SCHEMBL28299085 0.75 HDAC8 (0.36)
SCHEMBL20399655 0.75 POLB (0.35)
SCHEMBL457279 0.74
SCHEMBL2254634 0.73 CYP11B2 (0.39)
SCHEMBL455045 0.73 HTR2C (0.37)
SCHEMBL16953708 0.73
SCHEMBL16958384 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113307772-B Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2024-06-28 CN disclosed
CN-113307772-A Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2021-08-27 CN disclosed
CN-106257976-B Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2021-02-02 CN disclosed
CN-106257976-A Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2016-12-28 CN disclosed